Related Experiment Video

Updated: Aug 25, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.8K

[New treatment option for locally advanced dMMR/MSIhigh rectal cancer]

Stefan Kasper-Virchow1, Sirka Nitschmann2

  • 1Westdeutsches Tumorzentrum, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. stefan.kasper-virchow@uk-essen.de.

Innere Medizin (Heidelberg, Germany)
|October 19, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

2.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Experiment Videos

Last Updated: Aug 25, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.8K
Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

2.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

Articles linked to this work by shared authors, journal, and citation graph.

Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient Plasma.

Journal of extracellular biology·2026

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.

British journal of clinical pharmacology·2025

German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN).

European journal of cancer (Oxford, England : 1990)·2025

Significant Alterations of Colorectal Cancer Care in the COVID-19 Pandemic With High Adherence to Quality Criteria in German Cancer Centers (CC) ‒ Data From the AIO CancerCOVID Consortium (AIO-YMO/KRK 520/ass).

Clinical colorectal cancer·2025

[Nuclear medicine-necessity and opportunities in modern cardiology].

Innere Medizin (Heidelberg, Germany)·2026

[Echocardiography in cardiology-Basic tool, current developments and future perspectives].

Innere Medizin (Heidelberg, Germany)·2026

[Prevention and early detection of colorectal cancer].

Innere Medizin (Heidelberg, Germany)·2026

[Fever and rash after international travel: two cases of vaccine failure].

Innere Medizin (Heidelberg, Germany)·2026

[Psychosocial factors and long-term adherence to lifestyle interventions in individuals with type 2 diabetes mellitus].

Innere Medizin (Heidelberg, Germany)·2026

[Sarcopenia: diagnosis, clinical implications, and treatment].

Innere Medizin (Heidelberg, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us